Daniel Bensen's most recent trade in Tyra Biosciences Inc was a trade of 115,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 14, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 07 Jun 2024 | 3,502 | 427,981 | - | 20.0 | 70,045 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 07 Jun 2024 | 200 | 431,483 | - | 20 | 4,000 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 11 Mar 2024 | 200 | 431,683 | - | 20 | 4,000 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.09 per share. | 06 Mar 2024 | 1,733 | 431,951 | - | 20.1 | 34,819 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 06 Mar 2024 | 68 | 431,883 | - | 20 | 1,360 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.08 per share. | 01 Mar 2024 | 5,063 | 434,873 | - | 20.1 | 101,654 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.04 per share. | 01 Mar 2024 | 2,900 | 439,936 | - | 20.0 | 58,112 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.02 per share. | 01 Mar 2024 | 1,189 | 433,684 | - | 20.0 | 23,802 | Common Stock |
| Tyra Biosciences Inc | Bensen Daniel | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.13 per share. | 27 Feb 2024 | 5,849 | 444,886 | - | 20.1 | 117,729 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 27 Feb 2024 | 2,050 | 442,836 | - | 20.0 | 41,003 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 27 Feb 2024 | 745 | 450,735 | - | 20 | 14,900 | Common Stock |
| Tyra Biosciences Inc | Bensen Daniel | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 12 Feb 2024 | 1,501 | 451,480 | - | 20 | 30,020 | Common Stock |
| Tyra Biosciences Inc | Bensen Daniel | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.09 per share. | 07 Feb 2024 | 9,587 | 452,981 | - | 18.1 | 173,466 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.31 per share. | 02 Feb 2024 | 73,093 | 480,281 | - | 16.3 | 1,191,898 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 25,393 | 108,110 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 02 Feb 2024 | 25,393 | 553,374 | - | 0.6 | 15,490 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.09 per share. | 02 Feb 2024 | 15,413 | 462,568 | - | 18.1 | 278,827 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.04 per share. | 02 Feb 2024 | 2,300 | 477,981 | - | 17.0 | 39,199 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2023 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 13 Jul 2023 | 1,900 | 529,881 | - | 0.6 | 1,159 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2023 | 1,900 | 137,610 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.03 per share. | 13 Jul 2023 | 1,900 | 527,981 | - | 16.0 | 30,464 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 13 Jul 2023 | 500 | 528,481 | - | 0.6 | 305 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.13 per share. | 13 Jul 2023 | 500 | 527,981 | - | 16.1 | 8,065 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2023 | 500 | 139,510 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.01 per share. | 10 Jul 2023 | 1,202 | 527,981 | - | 16.0 | 19,240 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2023 | 1,202 | 140,711 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 10 Jul 2023 | 1,202 | 529,183 | - | 0.6 | 733 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2023 | 500 | 140,211 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.02 per share. | 10 Jul 2023 | 500 | 527,981 | - | 16.0 | 8,010 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 10 Jul 2023 | 500 | 528,481 | - | 0.6 | 305 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2023 | 201 | 140,010 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.23 per share. | 10 Jul 2023 | 201 | 527,981 | - | 16.2 | 3,262 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 10 Jul 2023 | 201 | 528,182 | - | 0.6 | 123 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2023 | 18,819 | 146,178 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.97 per share. | 29 Jun 2023 | 18,819 | 527,981 | - | 17.0 | 319,419 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 29 Jun 2023 | 18,819 | 546,800 | - | 0.6 | 11,480 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.49 per share. | 29 Jun 2023 | 17,281 | 527,981 | - | 16.5 | 285,014 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2023 | 17,281 | 164,997 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 29 Jun 2023 | 17,281 | 545,262 | - | 0.6 | 10,541 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2023 | 4,265 | 141,913 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 29 Jun 2023 | 4,265 | 532,246 | - | 0.6 | 2,602 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.30 per share. | 29 Jun 2023 | 3,865 | 528,381 | - | 16.3 | 63,000 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.04 per share. | 29 Jun 2023 | 400 | 527,981 | - | 17.0 | 6,814 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2023 | 17,232 | 211,830 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 26 Jun 2023 | 17,232 | 545,213 | - | 0.6 | 10,512 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2023 | 16,028 | 195,802 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 26 Jun 2023 | 16,028 | 544,009 | - | 0.6 | 9,777 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.91 per share. | 26 Jun 2023 | 13,524 | 527,981 | - | 16.9 | 228,637 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2023 | 13,524 | 182,278 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 26 Jun 2023 | 13,524 | 541,505 | - | 0.6 | 8,250 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.49 per share. | 26 Jun 2023 | 10,862 | 534,351 | - | 16.5 | 179,132 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.09 per share. | 26 Jun 2023 | 8,135 | 527,981 | - | 17.1 | 139,025 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.73 per share. | 26 Jun 2023 | 7,893 | 536,116 | - | 16.7 | 132,050 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.24 per share. | 26 Jun 2023 | 6,370 | 527,981 | - | 17.2 | 109,793 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 13 Jun 2023 | 12,592 | 540,573 | - | 0.6 | 7,681 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2023 | 12,592 | 229,062 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.15 per share. | 13 Jun 2023 | 12,592 | 527,981 | - | 16.1 | 203,302 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.01 per share. | 13 Jun 2023 | 5,628 | 527,981 | - | 16.0 | 90,129 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 13 Jun 2023 | 5,628 | 533,609 | - | 0.6 | 3,433 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2023 | 5,628 | 241,774 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 13 Jun 2023 | 120 | 528,101 | - | 0.6 | 73 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.45 per share. | 13 Jun 2023 | 120 | 527,981 | - | 16.5 | 1,974 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2023 | 120 | 241,654 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 30 Mar 2023 | 2,000 | 529,981 | - | 0.6 | 1,220 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.01 per share. | 30 Mar 2023 | 2,000 | 527,981 | - | 16.0 | 32,015 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2023 | 2,000 | 229,421 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2023 | 2,000 | 231,821 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.16 per share. | 30 Mar 2023 | 2,000 | 527,981 | - | 16.2 | 32,314 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 30 Mar 2023 | 2,000 | 529,981 | - | 0.6 | 1,220 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2023 | 400 | 231,421 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 30 Mar 2023 | 400 | 527,981 | - | 16 | 6,400 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 30 Mar 2023 | 400 | 528,381 | - | 0.6 | 244 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2023 | 8,048 | 239,354 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 27 Mar 2023 | 8,048 | 527,981 | - | 16 | 128,768 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 27 Mar 2023 | 8,048 | 536,029 | - | 0.6 | 4,909 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 27 Mar 2023 | 3,346 | 531,327 | - | 0.6 | 2,041 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2023 | 3,346 | 236,008 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 27 Mar 2023 | 3,346 | 527,981 | - | 16 | 53,536 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2023 | 2,187 | 233,821 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.21 per share. | 27 Mar 2023 | 2,187 | 527,981 | - | 16.2 | 35,459 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 27 Mar 2023 | 2,187 | 530,168 | - | 0.6 | 1,334 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 21 Mar 2023 | 14,100 | 527,981 | - | 16 | 225,600 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2023 | 14,100 | 256,029 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 21 Mar 2023 | 14,100 | 542,081 | - | 0.6 | 8,601 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2023 | 4,827 | 247,402 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 21 Mar 2023 | 4,827 | 527,981 | - | 16 | 77,232 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 21 Mar 2023 | 4,827 | 532,808 | - | 0.6 | 2,944 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2023 | 3,800 | 252,229 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 21 Mar 2023 | 3,800 | 527,981 | - | 16 | 60,800 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 21 Mar 2023 | 3,800 | 531,781 | - | 0.6 | 2,318 | Common Stock |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2022 | 249,532 | 249,532 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2022 | 105,000 | 105,000 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 83,626 | 83,626 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 7,964 | 7,964 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 7,964 | 7,964 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | 17 Sep 2021 | 8,501 | 527,981 | - | - | Common Stock | ||
| Tyra Biosciences Inc | Daniel Bensen | Chief Operating Officer | 17 Sep 2021 | 3,273 | 0 | - | - | Series A Preferred Stock |